A complete guide to Clinical Trials

Clinical trials play a vital role in the discovery, testing, and eventual marketing of new drugs. Over a million individuals participated in clinical trials during 2022/23, involving more than 6,000 studies. Understanding eligibility criteria for clinical trials can help you determine if you can contribute to advancements in the medical field.

A clinical trial is a medical study that tests a pharmaceutical drug, medical device, or other healthcare innovation on human participants. These trials aim to gather data on the safety and efficacy of new treatments compared to existing ones. Human volunteers are essential for these trials, providing valuable data that helps advance drug research and bring more effective treatments to market.

Eligibility for clinical trials varies depending on the study’s specific design. Common factors include age, gender, and the presence of a particular disease or condition. Your medical history is also crucial, as it helps determine whether it is safe for you to participate. Consulting with your doctor before enrolling in a trial is essential to assess your eligibility and potential risks.

Clinical trials require meticulous planning and a team of professionals. A company initiating a study must involve healthcare professionals to oversee the administration of treatments and ensure compliance with regulations. Researchers screen and recruit patients, collect data, and monitor progress throughout the trial. The planning phase includes creating a protocol outlining the study’s objectives, methods, and procedures.

Clinical trials are conducted in phases:

  • Phase 1: Evaluates the safety of a new drug or device in a small group, usually fewer than 100 participants, and determines safe dosage levels.
  • Phase 2: Involves 100 to 300 participants to assess the efficacy and side effects of the drug or device, lasting up to two years.
  • Phase 3: Compares the new intervention against current treatments with thousands of participants.
  • Phase 4: Conducted after the intervention is approved and on the market to gather additional long-term use data.

Before enrolling in a clinical trial, review all provided information, including leaflets and consent forms. Ensure you understand the trial’s purpose, potential risks, and benefits. Speak with trial staff and your healthcare provider to address any questions or concerns.

The clinical trial process begins with a screening interview. If eligible, you will need to provide informed consent, receive the treatment, and attend follow-up visits. Researchers collect data throughout the trial to create reports.

Understanding the trial’s purpose and the safety of the drugs or devices used is crucial. If the trial is in phase two or higher, inquire about any noted side effects. As a participant, you have the right to withdraw and should communicate any concerns or adverse reactions to the staff.

Clinical trials are essential for testing the safety and efficacy of new drugs. It is crucial to fully understand the process, how it works, and what to expect. For more information about enrolling in a clinical trial or questions about clinical trial safety, contact FluCamp.

hVIVO plc (formerly Open Orphan plc), led by Cathal Friel, is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials, providing end-to-end early clinical development services for its broad and long-standing client base of biopharma companies.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    hVIVO plc

    More articles like this

    hVIVO plc

    Accelerating vaccine development to combat the tripledemic

    The recent rise of the “tripledemic” – the simultaneous spread of the influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) – is posing significant risks, especially to older adults and those with chronic conditions or compromised

    hVIVO plc

    hVIVO plc announce Phase 2b Influenza Field Study Contract

    Highlights ·    hVIVO to enrol up to 1,000 healthy volunteers as part of a multicenter field study testing an influenza drug candidate, with hVIVO selected as the sole UK clinical site ·    Largest field study contract supporting a new income

    hVIVO plc

    The last smallpox outbreak and the future of vaccination

    Fifty years ago this month, India experienced its final seasonal smallpox epidemic. Nearly 200,000 infections were recorded, resulting in over 30,000 deaths. By May 1975, the last case of smallpox in India was diagnosed, and in

    hVIVO plc

    Travellers vaccines and the role of Human Challenge Trials

    A travellers’ vaccine is administered to individuals from non-endemic regions before they travel to areas where certain diseases are prevalent. These vaccines are crucial for travel medicine, protecting travellers and preventing the importation of vaccine-preventable diseases

    hVIVO plc

    hVIVO secures contract for Omicron characterisation study

    In June 2024, hVIVO announced a £2.5 million contract with a mid-sized pharmaceutical company to launch an Omicron characterisation study. This study aims to determine a dose of hVIVO’s Omicron BA.5 challenge agent that establishes a

    hVIVO plc

    hVIVO signs £2.5m contract for Omicron characterisation study

    hVIVO plc (LON:HVO), a fast growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced that it has signed a £2.5m contract with a mid-sized pharmaceutical company

    hVIVO plc

    Clinical Trial participation and eligibility requirements

    People who haven’t had the opportunity to participate in a clinical trial often wonder about eligibility criteria. Each trial has its own goals and purposes, so the inclusion criteria vary. Many trials require participants with specific

    hVIVO plc

    Importance of Clinical Trials in the medical industry

    Clinical trials play an important role in helping to ensure new drugs can be discovered, tested for safety and efficacy, and ultimately make their way onto the market. Over a million people took part in clinical trials during

    hVIVO plc

    European Mediscience Awards 2024 shortlist announced

    The European Mediscience Awards is now in its 22nd year, having been held every year since inception in 2002*. The event is the largest annual gathering of private and publicly quoted healthcare, biotech and life sciences companies in Europe.